IT-Treg cell ablation drives NK cell tumor control via CD4 Tconv cell–derived IL-2, eliminating MHC I+ or MHC I− cancers without systemic toxicity.
Intratumoral Treg cell ablation elicits NK cell–mediated control of CD8 T cell–resistant tumors | Science Immunology
